Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Ross

Showing results (51-60 of 130) with videos related to

Pageof 13
Sort By:
Scientific Reports|June 6, 2023
Platelets from patients with myeloproliferative neoplasms have increased numbers of mitochondria that are hypersensitive to depolarization by thrombinDavid M Ross, Hai Po Helena Liang, Zeenet Iqra, et al.
Leukemia & Lymphoma|June 9, 2020
Clinical utility of genomic DNA Q-PCR for the monitoring of a patient with atypical e19a2 <i>BCR-ABL1</i> transcripts in chronic myeloid leukemiaIlaria S Pagani, Phuong Dang, Verity A Saunders, et al.
Leukemia & Lymphoma|July 26, 2016
Busulfan is effective second-line therapy for older patients with Philadelphia-negative myeloproliferative neoplasms intolerant of or unresponsive to hydroxyureaGenevieve Douglas, Claire Harrison, Cecily Forsyth, et al.
Journal of Clinical Pathology|February 4, 2016
BCR-ABL1 expression, RT-qPCR and treatment decisions in chronic myeloid leukaemiaSusan Latham, Paul A Bartley, Bradley Budgen, et al.
The Journal of Molecular Diagnostics : JMD|January 3, 2015
A DNA real-time quantitative PCR method suitable for routine monitoring of low levels of minimal residual disease in chronic myeloid leukemiaPaul A Bartley, Susan Latham, Bradley Budgen, et al.
British Journal of Haematology|August 24, 2011
Clonal and lineage analysis of somatic DNMT3A and JAK2 mutations in a chronic phase polycythemia vera patientNisha Rao, Carolyn M Butcher, Ian D Lewis, et al.
Blood|April 11, 2019
Modeling the safe minimum frequency of molecular monitoring for CML patients attempting treatment-free remissionNaranie Shanmuganathan, Jodi A Braley, Agnes S M Yong, et al.
Internal Medicine Journal|November 10, 2018
Recommendations for the use of pegylated interferon-α in the treatment of classical myeloproliferative neoplasmsCecily J Forsyth, Wai-Hoong Chan, Andrew P Grigg, et al.
British Journal of Haematology|May 27, 2022
Highly sensitive droplet digital polymerase chain reaction for BCR::ABL1 messenger RNA identifies patients with chronic myeloid leukaemia with a low probability of achieving treatment-free remissionLiu Lu, Chung Hoow Kok, Phuong Dang, et al.
Blood Advances|January 9, 2023
Association of TIM-3 checkpoint receptor expression on T cells with treatment-free remission in chronic myeloid leukemiaYazad D Irani, Chung H Kok, Jade Clarson, et al.
Pageof 13

Showing results (51-60 of 130) with videos related to

Sort By:
Pageof 13
Scientific Reports|June 6, 2023
Platelets from patients with myeloproliferative neoplasms have increased numbers of mitochondria that are hypersensitive to depolarization by thrombinDavid M Ross, Hai Po Helena Liang, Zeenet Iqra, et al.
Leukemia & Lymphoma|June 9, 2020
Clinical utility of genomic DNA Q-PCR for the monitoring of a patient with atypical e19a2 <i>BCR-ABL1</i> transcripts in chronic myeloid leukemiaIlaria S Pagani, Phuong Dang, Verity A Saunders, et al.
Leukemia & Lymphoma|July 26, 2016
Busulfan is effective second-line therapy for older patients with Philadelphia-negative myeloproliferative neoplasms intolerant of or unresponsive to hydroxyureaGenevieve Douglas, Claire Harrison, Cecily Forsyth, et al.
Journal of Clinical Pathology|February 4, 2016
BCR-ABL1 expression, RT-qPCR and treatment decisions in chronic myeloid leukaemiaSusan Latham, Paul A Bartley, Bradley Budgen, et al.
The Journal of Molecular Diagnostics : JMD|January 3, 2015
A DNA real-time quantitative PCR method suitable for routine monitoring of low levels of minimal residual disease in chronic myeloid leukemiaPaul A Bartley, Susan Latham, Bradley Budgen, et al.
British Journal of Haematology|August 24, 2011
Clonal and lineage analysis of somatic DNMT3A and JAK2 mutations in a chronic phase polycythemia vera patientNisha Rao, Carolyn M Butcher, Ian D Lewis, et al.
Blood|April 11, 2019
Modeling the safe minimum frequency of molecular monitoring for CML patients attempting treatment-free remissionNaranie Shanmuganathan, Jodi A Braley, Agnes S M Yong, et al.
Internal Medicine Journal|November 10, 2018
Recommendations for the use of pegylated interferon-α in the treatment of classical myeloproliferative neoplasmsCecily J Forsyth, Wai-Hoong Chan, Andrew P Grigg, et al.
British Journal of Haematology|May 27, 2022
Highly sensitive droplet digital polymerase chain reaction for BCR::ABL1 messenger RNA identifies patients with chronic myeloid leukaemia with a low probability of achieving treatment-free remissionLiu Lu, Chung Hoow Kok, Phuong Dang, et al.
Blood Advances|January 9, 2023
Association of TIM-3 checkpoint receptor expression on T cells with treatment-free remission in chronic myeloid leukemiaYazad D Irani, Chung H Kok, Jade Clarson, et al.
Pageof 13